Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...

Dr. Ghyslain Mombo-Ngoma led a study in Gabon in which researchers gave a single-dose treatment combining an artemisinin with ...

Hundreds of malaria patients enrolled in a phase 3 clinical trial in Gabon, West Africa, were successfully treated with a one ...

The drug, known as GanLum, is made by Swiss pharmaceutical giant Novartis. In a late-stage trial, it worked about as well as ...

For many Gabonese, malaria remains a constant struggle. Libreville resident Julicia Nfono says the disease keeps coming back ...

Gabonese researchers at the Lambarene Medical Research Center (CERMEL) have achieved a major scientific breakthrough in the fight against endemic malaria by developing a new, highly effective ...

Switzerland-based Novartis has developed a new anti-malaria drug, GanLum, that showed 97% effectiveness in late-stage trials.

Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could help predict the severity of the disease and thus enable faster treatment for ...

Deaths from the mosquito-borne illness malaria disproportionately affect children under the age of 5—more than 1,200 children ...

Papua accounted for 93% of Indonesia's 527,000 malaria cases in 2024, as elimination efforts continue to face multiple ...

According to posts doing the rounds on Facebook in South Africa, bitter leaf is rich in quinine, a compound which can “cure malaria”. “It ...

Researchers on Wednesday reported two promising new approaches to counteract malaria's growing resistance to medication — one ...